Bausch Health Cos., Inc. (BHC.TO)
8.64
+0.04
(+0.47%)
CAD |
TSX |
Oct 09, 16:00
Bausch Health Cos. Enterprise Value : 31.48B for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 31.48B |
| October 08, 2026 | 31.46B |
| October 07, 2026 | 31.53B |
| October 06, 2026 | 31.45B |
| October 05, 2026 | 31.40B |
| October 02, 2026 | 31.34B |
| October 01, 2026 | 31.29B |
| September 30, 2026 | 31.35B |
| September 29, 2026 | 31.31B |
| September 28, 2026 | 31.31B |
| September 25, 2026 | 31.26B |
| September 24, 2026 | 31.23B |
| September 23, 2026 | 31.25B |
| September 22, 2026 | 31.30B |
| September 21, 2026 | 31.21B |
| September 18, 2026 | 31.21B |
| September 17, 2026 | 31.21B |
| September 16, 2026 | 31.23B |
| September 15, 2026 | 31.19B |
| September 14, 2026 | 31.33B |
| September 11, 2026 | 31.28B |
| September 10, 2026 | 31.40B |
| September 09, 2026 | 31.43B |
| September 08, 2026 | 31.56B |
| September 04, 2026 | 31.63B |
| Date | Value |
|---|---|
| September 03, 2026 | 31.73B |
| September 02, 2026 | 31.78B |
| September 01, 2026 | 31.62B |
| August 31, 2026 | 31.53B |
| August 28, 2026 | 31.53B |
| August 27, 2026 | 31.52B |
| August 26, 2026 | 31.62B |
| August 25, 2026 | 31.73B |
| August 24, 2026 | 31.70B |
| August 21, 2026 | 31.55B |
| August 20, 2026 | 31.77B |
| August 19, 2026 | 31.79B |
| August 18, 2026 | 31.86B |
| August 17, 2026 | 31.65B |
| August 14, 2026 | 31.62B |
| August 13, 2026 | 31.55B |
| August 12, 2026 | 31.47B |
| August 11, 2026 | 31.49B |
| August 10, 2026 | 31.55B |
| August 07, 2026 | 31.50B |
| August 06, 2026 | 31.34B |
| August 05, 2026 | 31.54B |
| August 04, 2026 | 31.64B |
| July 31, 2026 | 31.86B |
| July 30, 2026 | 31.40B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| HLS Therapeutics, Inc. | 167.86M |
| Cipher Pharmaceuticals, Inc. | 334.51M |
| BioSyent, Inc. | 188.68M |
| Revive Therapeutics Ltd. | 10.94M |
| Knight Therapeutics, Inc. | 988.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 359.94M |
| Revenue (Quarterly) | 3.948B |
| Total Expenses (Quarterly) | 3.591B |
| EPS Diluted (Quarterly) | 0.9446 |
| Gross Profit Margin (Quarterly) | 65.04% |
| Profit Margin (Quarterly) | 9.12% |
| Earnings Yield | -46.95% |
| Operating Earnings Yield | 116.8% |
| Normalized Earnings Yield | 8.843 |